Specialty Drug, Specialty Pharmacy
Amber Specialty Pharmacy Selected by Takeda to Dispense LIVTENCITY™
13
Dec
Dec
Amber Specialty Pharmacy announced that it will begin dispensing LIVTENCITY™ (maribavir), the first and only treatment indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease
